Statins × cardiovascular events

TrialThe New England journal of medicine2009

Fluvastatin and perioperative events in patients undergoing vascular surgery.

Olaf Schouten et al.PubMed ↗Publisher ↗

  • Fluvastatinlooks good hereFewer deaths from cardiovascular causes or myocardial infarction.Randomised, small.

What the trial testedrandomised · 250 people · 2009

Randomised vs placebo

Probably reduced deaths from cardiovascular causes or myocardial infarction

−53%−76% to −6%

fluvastatin vs placebo

5 in 100 instead of 10

Bigger than 9 in 10 for cardiovascular events

As reported

HR 0.47, 95% CI 0.24–0.94 · the paper's word: Death from cardiovascular causes or myocardial infarction

Who was studied, and how

648people in the Multicenter Randomized Controlled Trial of Loading Dose Statins for the Prevention of Cardiovascular Complications in High-Risk Non-Cardiac Surgery trial, from 2012
250of them with cardiovascular disease, in this paper

The trial randomly assignedassigned by chance

fluvastatin
placebo

Probably reduced deaths from cardiovascular causes or myocardial infarction−53%

randomised

the abstract, start to end

in the placebo group (hazard ratio, 0.47; 95% CI, 0.24 to 0.94; P=0.03).

← favours treatmentfavours comparator →
could be chance
Death from cardiovascular causes or myocardial infarctionfluvastatin vs placebo
HR 0.470.24–0.94
StatinsCardiovascular events

Statins × cardiovascular eventshelps?replicated

unlikelylikely
0.860.85 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 6

73 papers cite itlatest 60 shown

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2024
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 19726772